For a show about men - and some women, but mostly men - working to build the future, "The Audacity" feels a little ...
Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.
Development communications expert Damilola Bakare of the Aig-Imoukhuede Foundation has highlighted the deeper realities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results